- Home
- About
- About NephU
- Meet The Team
- Supporting Organizations
- Community Advisors
- Contact Us
- Diversity, Equity, & Inclusion
- IgAN
- Events
- Resource Center
- Rare Kidney Diseases (PKD, IgAN, & Others)
- Kidney Disease & Mental Health
- Kidney Disease & Comorbid Conditions
- Transplantation & Dialysis
- NephU Nutrition & The NephChefR
- Radiology Toolkit
- On Demand Webinars
- Infographics
- Podcasts
- Videos
- Request a Presentation
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Archives
IgA Nephropathy – From Pathogenesis to Current Management
About This Event
IgA Nephropathy – From Pathogenesis to Current Management
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide. During this presentation you will learn the clinical presentation, diagnosis, prognosis, and unmet treatment needs of IgAN. You will then take a deep dive into the current understanding of IgAN pathogenesis including the four hit cascade and the key role B-cells and APRIL (A PRoliferation-Inducing Ligand) play in driving disease progression.
Location
The Bowman
Featuring
Alf Carroll, DMSc, PA-C
Nephrology Senior Medical Science LiaisonOtsuka Pharmaceutical Development & Commercialization, Inc.*
Alf Carroll, DMSc, PA-C is a Senior Medical Science Liaison at Otsuka Pharmaceutical Development and Commercialization. He earned his Bachelor of Science in Biology and Master of Science in Physician Assistant Studies from Northeastern University in Boston, Massachusetts. He worked clinically as a Physician Assistant in the Emergency Department at Massachusetts General Hospital and South Shore Hospital in the Boston area. Prior to joining Otsuka, Alf held a position at AstraZeneca Pharmaceuticals on their Market Access team focusing on large health systems in New England, covering the cardiovascular, renal, endocrine, and respiratory therapeutic areas.
Kimberly Means, PharmD, BCCCP, BSN, RN
Medical Science LiaisonOtsuka Pharmaceutical Development & Commercialization, Inc.*
Kimberly Means, PharmD, BCCCP, BSN, RN, is a Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Means earned her B.S. in Nursing (BSN) and her Doctor of Pharmacy (PharmD) from Virginia Commonwealth University (VCU) in Richmond, Virginia. She completed a PGY-1 Pharmacy Practice Residency and a PGY-2 Critical Care Residency at VCU Health in Richmond, Virginia. Prior to joining Otsuka, she worked as a critical care nurse at VCU Health, a Critical Care Clinical Pharmacist at Henrico Doctors’ Hospital, and a Clinical Pharmacist in Surgical Services at VCU Health. During her time as a Clinical Assistant Professor at the VCU School of Pharmacy and VCU Health she served as a preceptor for pharmacy students and pharmacy residents. Dr Means is a Board Certified Critical Care Pharmacotherapy Specialist (BCCCP).
Alf Carroll, DMSc, PA-C and Kimberly Means, PharmD, BCCCP, BSN, RN are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Registration
Related Events
-
Cooking Demo: Dietary Considerations for Patients with IgA Nephropathy
January 8, 2025 from 12:00 pm to 1:00 pm
Join Today for Instant Access to all NephU Offerings.
Membership is free!
Join NephU today at no cost to register for this event and access to other premium content.
- The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
- Quickly learn more about the topics that interest you.
- Access our library of on-demand kidney health resources
- Gain key insights from industry experts & though leaders.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved.